| Developmental pharmacology—drug disposition, action, and therapy in infants and children GL Kearns, SM Abdel-Rahman, SW Alander, DL Blowey, JS Leeder, ... New England Journal of Medicine 349 (12), 1157-1167, 2003 | 2752 | 2003 |
| Handbook of basic pharmacokinetics WA Ritschel (No Title), 1980 | 977 | 1980 |
| Cytochrome P450 3A: ontogeny and drug disposition SN de Wildt, GL Kearns, JS Leeder, JN van den Anker Clinical pharmacokinetics 37, 485-505, 1999 | 729 | 1999 |
| Glucuronidation in humans: pharmacogenetic and developmental aspects SN de Wildt, GL Kearns, JS Leeder, JN van den Anker Clinical pharmacokinetics 36, 439-452, 1999 | 489 | 1999 |
| Developmental changes in pharmacokinetics and pharmacodynamics J van den Anker, MD Reed, K Allegaert, GL Kearns The Journal of Clinical Pharmacology 58, S10-S25, 2018 | 347 | 2018 |
| Proton pump inhibitors in pediatrics: mechanism of action, pharmacokinetics, pharmacogenetics, and pharmacodynamics RM Ward, GL Kearns Pediatric Drugs 15, 119-131, 2013 | 249 | 2013 |
| Pharmacogenetics in pediatrics: implications for practice JS Leeder, GL Kearns Pediatric Clinics of North America 44 (1), 55-77, 1997 | 246 | 1997 |
| Optimization of cytochrome P4502D6 (CYP2D6) phenotype assignment using a genotyping algorithm based on allele frequency data A Gaedigk, RR Gotschall, NS Forbes, SD Simon, GL Kearns, JS Leeder Pharmacogenetics and Genomics 9 (6), 669-682, 1999 | 243 | 1999 |
| Clinical pharmacokinetics in infants and children: a reappraisal GL Kearns, MD Reed Clinical pharmacokinetics 17 (Suppl 1), 29-67, 1989 | 236 | 1989 |
| Ontogeny of drug metabolizing enzymes in the neonate MJ Blake, L Castro, JS Leeder, GL Kearns Seminars in Fetal and Neonatal Medicine 10 (2), 123-138, 2005 | 216 | 2005 |
| Acute hepatic failure associated with the use of sodium valproate: report of two fatal cases FJ Suchy, WF Balistreri, JJ Buchino, JM Sondheimer, SR Bates, ... New England Journal of Medicine 300 (17), 962-966, 1979 | 215 | 1979 |
| The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants GP Heresi, DR Gerstmann, MD Reed, JN van den Anker, JL Blumer, ... The Pediatric infectious disease journal 25 (12), 1110-1115, 2006 | 209 | 2006 |
| Combined phenotypic assessment of cytochrome P450 1A2, 2C9, 2C19, 2D6, and 3A, N‐acetyltransferase‐2, and xanthine oxidase activities with the … S Chainuvati, AN Nafziger, JS Leeder, A Gaedigk, GL Kearns, E Sellers, ... Clinical pharmacology & therapeutics 74 (5), 437-447, 2003 | 199 | 2003 |
| Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N‐acetyltransferase‐2, and xanthine oxidase with the “Cooperstown cocktail” DS Streetman, JF Bleakley, JS Kim, AN Nafziger, JS Leeder, A Gaedigk, ... Clinical Pharmacology & Therapeutics 68 (4), 375-383, 2000 | 186 | 2000 |
| The physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders BP Chumpitazi, GL Kearns, RJ Shulman Alimentary pharmacology & therapeutics 47 (6), 738-752, 2018 | 172 | 2018 |
| Pharmacokinetics of an elevated dosage of micafungin in premature neonates PB Smith, TJ Walsh, W Hope, A Arrieta, A Takada, LL Kovanda, ... The Pediatric infectious disease journal 28 (5), 412-415, 2009 | 171 | 2009 |
| Ontogeny of Dextromethorphan O‐ and N‐demethylation in the First Year of Life MJ Blake, A Gaedigk, RE Pearce, LR Bomgaars, ML Christensen, ... Clinical Pharmacology & Therapeutics 81 (4), 510-516, 2007 | 166 | 2007 |
| Single‐dose pharmacokinetics of ibuprofen and acetaminophen in febrile children RD Brown, JT Wilson, GL Kearns, VF Eichler, VA Johnson, KM Bertrand The Journal of Clinical Pharmacology 32 (3), 231-241, 1992 | 163 | 1992 |
| Encouraging AWaRe-ness and discouraging inappropriate antibiotic use—the new 2019 Essential Medicines List becomes a global antibiotic stewardship tool M Sharland, S Gandra, B Huttner, L Moja, C Pulcini, M Zeng, ... The Lancet Infectious Diseases 19 (12), 1278-1280, 2019 | 162 | 2019 |
| Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus B Van Overmeire, D Touw, PJC Schepens, GL Kearns, JN van den Anker Clinical Pharmacology & Therapeutics 70 (4), 336-343, 2001 | 157 | 2001 |
